These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2889 related articles for article (PubMed ID: 32524748)
21. How accurate is Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066 [TBL] [Abstract][Full Text] [Related]
22. Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging. Meijer D; van Leeuwen PJ; Donswijk ML; Boellaard TN; Schoots IG; van der Poel HG; Hendrikse HN; Oprea-Lager DE; Vis AN BJU Int; 2022 Jan; 129(1):54-62. PubMed ID: 34028165 [TBL] [Abstract][Full Text] [Related]
23. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer. Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483 [TBL] [Abstract][Full Text] [Related]
24. Detection and localisation of primary prostate cancer using Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602 [TBL] [Abstract][Full Text] [Related]
25. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy. Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524 [TBL] [Abstract][Full Text] [Related]
26. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool. Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378 [TBL] [Abstract][Full Text] [Related]
27. Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy. Huang C; Song G; Wang H; Lin Z; Wang H; Ji G; Zhang S; Guo Y; Li J; Bao Z; Hong P; Du Y; Li P; He Q; He S; Gong Y; Wang X; Zhou L Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):116-126. PubMed ID: 31383954 [TBL] [Abstract][Full Text] [Related]
28. Comparing the diagnostic value of Xiong Z; Ge Y; Ma S; Wang Y; Li L; Chao Z; Wang X; Sulaiman M; Li C; Luan Y; Yang C; Zeng X; Yu G; Zou S; Zhu X; Wang S; Hu Z; Yang Q; Qin B; Wang Z Transl Androl Urol; 2024 Jul; 13(7):1219-1227. PubMed ID: 39100834 [TBL] [Abstract][Full Text] [Related]
29. Clinical parameters and nomograms for predicting lymph node metastasis detected with Onal C; Ozyigit G; Oymak E; Guler OC; Hurmuz P; Tilki B; Reyhan M; Tuncel M; Akyol F Prostate; 2021 Jul; 81(10):648-656. PubMed ID: 33949694 [TBL] [Abstract][Full Text] [Related]
30. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
31. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer. Touijer KA; Michaud L; Alvarez HAV; Gopalan A; Kossatz S; Gonen M; Beattie B; Sandler I; Lyaschenko S; Eastham JA; Scardino PT; Hricak H; Weber WA Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093 [TBL] [Abstract][Full Text] [Related]
32. Multiparametric MRI and Privé BM; Israël B; Janssen MJR; van der Leest MMG; de Rooij M; van Ipenburg JA; Jonker M; Peters SMB; de Groot M; Zámecnik P; Hoepping A; Bomers JG; Gotthardt M; Sedelaar JPM; Barentsz JO; van Oort IM; Nagarajah J Radiology; 2024 May; 311(2):e231879. PubMed ID: 38771185 [TBL] [Abstract][Full Text] [Related]
33. A comparison between Frumer M; Milk N; Rinott Mizrahi G; Bistritzky S; Sternberg I; Leibovitch I; Dekel Y; Amiel GE; Zisman A; Baniel J; Haifler M; Gal J; Hoffman A; Sagy I; Rosenzweig B; Haramaty R; Golan S Abdom Radiol (NY); 2020 Dec; 45(12):4194-4201. PubMed ID: 32671440 [TBL] [Abstract][Full Text] [Related]
34. External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study. Meijer D; van Leeuwen PJ; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Oprea-Lager DE; Coughlin GD; Vis AN Eur Urol; 2021 Aug; 80(2):234-242. PubMed ID: 34024652 [TBL] [Abstract][Full Text] [Related]
35. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature. Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398 [TBL] [Abstract][Full Text] [Related]
36. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard. Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770 [TBL] [Abstract][Full Text] [Related]
37. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography. Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ Eur Urol Oncol; 2023 Dec; 6(6):553-563. PubMed ID: 37045707 [TBL] [Abstract][Full Text] [Related]
38. Ferraro DA; Muehlematter UJ; Garcia Schüler HI; Rupp NJ; Huellner M; Messerli M; Rüschoff JH; Ter Voert EEGW; Hermanns T; Burger IA Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):147-159. PubMed ID: 31522272 [TBL] [Abstract][Full Text] [Related]
39. The diagnostic accuracy of Rajwa P; Heidenreich J; Drzezga A; Schmidt M; Shariat SF; Heidenreich A Prostate; 2024 Jan; 84(1):74-78. PubMed ID: 37750292 [TBL] [Abstract][Full Text] [Related]
40. Re: Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Montorsi F; Gandaglia G; Fossati N; Dehò F; Briganti A BJU Int; 2021 Jun; 127(6):746. PubMed ID: 33249715 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]